text-only page produced automatically by LIFT Text Transcoder Skip all navigation and go to page contentSkip top navigation and go to directorate navigationSkip top navigation and go to page navigation
National Science Foundation
News
design element
News
News From the Field
For the News Media
Special Reports
Research Overviews
NSF-Wide Investments
Speeches & Lectures
NSF Current Newsletter
Multimedia Gallery
Search Multimedia
Image
Video
Audio
More
Multimedia in the News
NSF Executive Staff
News Archive
 

Email this pagePrint this page
"Small Wonder" -- The Discovery Files


The Discovery Files
Audio Play Audio
The Discovery Files podcast is available through iTunes or you can add the RSS feed to your podcast receiver.

A laboratory test used to detect disease and perform biological research could be made more than three million times more sensitive, according to Princeton University researchers who combined standard biological tools with a breakthrough in nanotechnology.

Credit: NSF/Karson Productions

Audio Transcript:

Small wonder.

I'm Bob Karson with the discovery files--new advances in science and engineering from the National Science Foundation.

Biomarkers--telltale signs that can help doctors detect the presence of cancer, Alzheimer's and other conditions. A laboratory test called an immunoassay is used to detect those markers. When biomarkers are present in a sample of blood, urine or saliva, the test produces a fluorescent glow. The brighter the glow, the more markers present. But if the amount of biomarkers is too small, the light is too faint to detect.

Now researchers at Princeton have found a way to make the tests more sensitive--about three million times more sensitive. In other words, you need three million times less biomarkers to reveal the presence of certain disorders. They developed glass and gold nanostructures--that dramatically amplify the faint fluorescence from a sample. Their new method could result in significantly earlier detection and treatment.

Next the researchers are comparing their enhanced immunoassay with conventional ones in detecting breast and prostate cancers. They're developing tests to detect proteins associated with Alzheimer's at a very early stage. New light on early detection it could mean a brighter future for patients.

"The discovery files" covers projects funded by the government's national science foundation. Federally sponsored research--brought to you, by you! Learn more at nsf.gov or on our podcast.

 
General Restrictions:
Images and other media in the National Science Foundation Multimedia Gallery are available for use in print and electronic material by NSF employees, members of the media, university staff, teachers and the general public. All media in the gallery are intended for personal, educational and nonprofit/non-commercial use only.

Images credited to the National Science Foundation, a federal agency, are in the public domain. The images were created by employees of the United States Government as part of their official duties or prepared by contractors as "works for hire" for NSF. You may freely use NSF-credited images and, at your discretion, credit NSF with a "Courtesy: National Science Foundation" notation. Additional information about general usage can be found in Conditions.

MP3 icon
NSF podcasts are in mp3 format for easy download to desktop and laptops, as well as mobile devices capable of playing them.

 



Email this pagePrint this page
Back to Top of page